MENU

Movement Disorders

The Latest
More in Movement Disorders
Physical and Cognitive Activity for Dementia image

Cover Focus

Physical and Cognitive Activity for Dementia

There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.

Ajay Sood, MD, PhD, and David Bennett, MD

Dementia Innovations image

Guest Medical Editor's Page

Dementia Innovations

After years in development, many innovations are poised to move into clinical practice.

Nupur Ghoshal, MD, PhD

News

11.09.20

FDA Clears IND Application of Gene Therapy for Tay-Sachs and Sandhoff Diseases
  • KEYWORDS:
  • AXO-AAV-GM2
  • FDA Clearance
  • Sandhoff Diseases
  • Tay-Sachs Disease

News

11.09.20

Neflamapimod Improves Cognition in Dementia With Lewy Bodies in Phase 2 Trial
  • KEYWORDS:
  • Dementia
  • Lewy body dementia
  • Neflamapimod
  • Parkinson disease
  • Parkinson disease psychosis

News

10.23.20

FDA Grants Breakthrough Device Status to External Neuromodulator for Essential Tremor
  • KEYWORDS:
  • Movement disorders
  • Neuromodulation
  • Parkinson disease
Movement Disorders Moment: Treatment
Approaches to Cervical Dystonia image

Columns

Movement Disorders Moment: Treatment Approaches to Cervical Dystonia

Botulinum toxins are effective treatment.

Zehra Farzal, MD; Guillaume Lamotte MD, MSc; Elizabeth Mundel, MD; Laxman B. Bahroo, DO; and Fernando L. Pagan, MD

News

10.16.20

DaxibotulinumtoxinA Provides Clinically Meaningful Improvement of Cervical Dystonia in Phase 3 Trial
  • KEYWORDS:
  • Cervical dystonia
  • DaxibotulinumtoxinA
  • Dystonia
  • Movement disorders
  • Neuromuscular disease

News

10.06.20

Gene Therapy Improves ON Time for Individuals With Parkinson Disease in Phase 3 Trial
  • KEYWORDS:
  • Gene therapy
  • Movement disorders
  • Parkinson disease

News

09.23.20

Individuals with Parkinson Disease More Likely to Have Orthostatic Hypotension
  • KEYWORDS:
  • Movement disorders
  • Neurogenic orthostatic hypotension
  • Parkinson disease

News

09.17.20

Opicapone Decreases Off Time in Parkinson Disease 
  • KEYWORDS:
  • Movement disorders
  • opicapone
  • Parkinson disease
Trending Autoantibodies Causing Movement Disorders image

Cover Focus

Trending Autoantibodies Causing Movement Disorders

As new autoantibodies are described, the field of autoimmune movement disorders is ever expanding.

F. Stephen Benesh, MD, and Shruti P. Agnihotri, MD

Immune-Mediated Cerebellar Ataxias image

Cover Focus

Immune-Mediated Cerebellar Ataxias

Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.

Fabio Fieni Toso, MD; Rene de Araújo Gleizer, MD; and Lívia Almeida Dutra, MD, PhD

Stiff-Person Syndrome image

Cover Focus

Stiff-Person Syndrome

Treatment consists of immunomodulatory therapies and symptom management.

Jakai D. Nolan, DO, MPH, and Jacqueline A. Nicholas, MD, MPH

Show More